A federal advisory panel offered a bevy of suggestions about how the FDA might proceed with potential future clearances for the broad use of tools intended to analyze skin lesions for cancer risk.
Early-Life Triggers May Prime Cells to Unleash Exaggerated Immune Responses. The surprise discovery of a new type of cell explains how distress to the skin early in life may prime a person for inflammatory skin disease later, according to a new.